{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:15:26Z","timestamp":1790129726907,"version":"4.0.1"},"reference-count":116,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T00:00:00Z","timestamp":1547251200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"National Institute for Health Research Health Protection Research Unit"},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Senior Research Fellowship"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,1]]},"DOI":"10.1093\/jac\/dky548","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T12:13:37Z","timestamp":1543839217000},"page":"1157-1166","source":"Crossref","is-referenced-by-count":77,"title":["Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: a review"],"prefix":"10.1093","volume":"74","author":[{"given":"Fabian Yuh Shiong","family":"Kong","sequence":"first","affiliation":[{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Horner","sequence":"additional","affiliation":[{"name":"Population Health Sciences, University of Bristol, Oakfield House, Oakfield Grove, Bristol, UK"},{"name":"National Institute for Health Research Health Protection Research Unit in Evaluation of Interventions, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[{"name":"WHO Collaborating Centre for Gonorrhoea and Other STIs, National Reference Laboratory for Sexually Transmitted Infections, Department of Laboratory Medicine, Microbiology, \u00d6rebro University, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane S","family":"Hocking","sequence":"additional","affiliation":[{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"key":"2019042309331412200_dky548-B1","doi-asserted-by":"crossref","first-page":"e0143304.","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PloS One"},{"key":"2019042309331412200_dky548-B2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/sextrans-2017-053384","article-title":"Prevalence of Mycoplasma genitalium in different population groups: systematic review and meta-analysis","volume":"94","author":"Baumann","year":"2018","journal-title":"Sex Transm Infect"},{"key":"2019042309331412200_dky548-B3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cmi.2017.09.006","article-title":"Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016","volume":"24","author":"Unemo","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2019042309331412200_dky548-B4","first-page":"1","article-title":". Sexually transmitted diseases treatment guidelines, 2015","volume":"64","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"2019042309331412200_dky548-B5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/428290","article-title":"Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report","volume":"191","author":"Wang","year":"2005","journal-title":"J Infect Dis"},{"key":"2019042309331412200_dky548-B6","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1101\/gr.212647.116","article-title":"Comprehensive global genome dynamics of Chlamydia trachomatis show ancient diversification followed by contemporary mixing and recent lineage expansion","volume":"27","author":"Hadfield","year":"2017","journal-title":"Genome Res"},{"key":"2019042309331412200_dky548-B7","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/jac\/dku574","article-title":"The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis","volume":"70","author":"Kong","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2019042309331412200_dky548-B8","doi-asserted-by":"crossref","first-page":"e1002344.","DOI":"10.1371\/journal.pmed.1002344","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action","volume":"14","author":"Wi","year":"2017","journal-title":"PLoS Med"},{"key":"2019042309331412200_dky548-B9","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/jdv.13849","article-title":"2016 European guideline on Mycoplasma genitalium infections","volume":"30","author":"Jensen","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2019042309331412200_dky548-B10","doi-asserted-by":"crossref","first-page":"139.","DOI":"10.1038\/nrurol.2016.268","article-title":"Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium","volume":"14","author":"Unemo","year":"2017","journal-title":"Nat Rev Urol"},{"key":"2019042309331412200_dky548-B11","year":"2016"},{"key":"2019042309331412200_dky548-B12","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/jdv.12734","article-title":"2014 European guideline on the management of syphilis","volume":"28","author":"Janier","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2019042309331412200_dky548-B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6507a1","article-title":"Neisseria gonorrhoeae antimicrobial susceptibility surveillance \u2013 the Gonococcal Isolate Surveillance Project, 27 sites, United States, 2014","volume":"65","author":"Kirkcaldy","year":"2016","journal-title":"MMWR Surveill Summ"},{"key":"2019042309331412200_dky548-B14","year":"2014"},{"key":"2019042309331412200_dky548-B15","doi-asserted-by":"crossref","first-page":"e1002366.","DOI":"10.1371\/journal.pmed.1002366","article-title":"Multidrug-resistant gonorrhea: a research and development roadmap to discover new medicines","volume":"14","author":"Alirol","year":"2017","journal-title":"PLoS Med"},{"key":"2019042309331412200_dky548-B16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/0956462415618837","article-title":"2015 European guideline on the management of Chlamydia trachomatis infections","volume":"27","author":"Lanjouw","year":"2016","journal-title":"Int J STD AIDS"},{"key":"2019042309331412200_dky548-B17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0956462412472837","article-title":"2012 European guideline on the diagnosis and treatment of gonorrhoea in adults","volume":"24","author":"Bignell","year":"2013","journal-title":"Int J STD AIDS"},{"key":"2019042309331412200_dky548-B18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ijantimicag.2010.01.023","article-title":"Class-dependent relevance of tissue distribution in the interpretation of anti-infective pharmacokinetic\/pharmacodynamic indices","volume":"35","author":"Barbour","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"2019042309331412200_dky548-B19","volume-title":"Zithromax Product Information","year":"2013"},{"key":"2019042309331412200_dky548-B20","volume-title":"Zithromax Product Information","year":"2008"},{"key":"2019042309331412200_dky548-B21","author":"Grayson","year":"2011","edition":"6"},{"key":"2019042309331412200_dky548-B22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1128\/AAC.27.2.192","article-title":"Single-dose pharmacokinetics of ceftriaxone in healthy Chinese adults","volume":"27","author":"Zhou","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309331412200_dky548-B23","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/AAC.24.5.812","article-title":"Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers","volume":"24","author":"Meyers","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309331412200_dky548-B24","first-page":"959","article-title":"Cefixime; disposition kinetics and bioavailability comparison of two formulations of cefixime in healthy adult male subjects","volume":"22","author":"Ashraf","year":"2015","journal-title":"Prof Med J"},{"key":"2019042309331412200_dky548-B25","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1086\/321854","article-title":"Does the dose matter?","volume":"33","author":"Craig","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2019042309331412200_dky548-B26","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1128\/AAC.02904-14","article-title":"Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects","volume":"58","author":"Zheng","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309331412200_dky548-B27","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.trac.2007.09.004","article-title":"Determination of pKa values of active pharmaceutical ingredients","volume":"26","author":"Babi\u0107","year":"2007","journal-title":"Trends Anal Chem"},{"key":"2019042309331412200_dky548-B28","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-55041-6","volume-title":"Tactics in Contemporary Drug Design","author":"Meanwell","year":"2015"},{"key":"2019042309331412200_dky548-B29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1086\/514619","article-title":"Pharmacodynamics of macrolides, azalides, and streptogramins: effect on extracellular pathogens","volume":"27","author":"Carbon","year":"1998","journal-title":"Clin Infect Dis"},{"key":"2019042309331412200_dky548-B30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF02629003","article-title":"Contact pH of rectal mucosa in humans and dogs","volume":"12","author":"Bitterman","year":"1969","journal-title":"Dis Colon Rectum"},{"key":"2019042309331412200_dky548-B31","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/OGX.0b013e3181e09621","article-title":"Diagnosis and management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: a review","volume":"65","author":"Donders","year":"2010","journal-title":"Obstet Gynecol Surv"},{"key":"2019042309331412200_dky548-B32","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00007435-200209000-00004","article-title":"Examination of Chlamydia trachomatis infection in environments mimicking normal and abnormal vaginal pH","volume":"29","author":"Yasin","year":"2002","journal-title":"Sex Transm Dis"},{"key":"2019042309331412200_dky548-B33","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/S1473-3099(17)30310-9","article-title":"Sexually transmitted infections: challenges ahead","volume":"17","author":"Unemo","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2019042309331412200_dky548-B34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0015-0282(16)55810-5","article-title":"The pH as an important determinant of sperm-mucus interaction","volume":"59","author":"Eggert-Kruse","year":"1993","journal-title":"Fertil Steril"},{"key":"2019042309331412200_dky548-B35","first-page":"1","article-title":", Esteves SC. Insights into the role of cervical mucus and vaginal pH in unexplained infertility","volume":"2","author":"Nakano","year":"2015","journal-title":"MedicalExpress"},{"key":"2019042309331412200_dky548-B36","first-page":"244","article-title":"Azithromycin levels in cervical mucus and plasma after a single 1.0g oral dose for chlamydial cervicitis","volume":"71","author":"Worm","year":"1995","journal-title":"Genitourin Med"},{"key":"2019042309331412200_dky548-B37","doi-asserted-by":"crossref","first-page":"e0174372.","DOI":"10.1371\/journal.pone.0174372","article-title":"Pharmacokinetics of a single 1g dose of azithromycin in rectal tissue in men","volume":"12","author":"Kong","year":"2017","journal-title":"PLoS One"},{"key":"2019042309331412200_dky548-B38","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1902\/jop.1999.70.9.960","article-title":"Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases","volume":"70","author":"Blandizzi","year":"1999","journal-title":"J Periodontol"},{"key":"2019042309331412200_dky548-B39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00044011-199815020-00009","article-title":"Pharmacokinetics of oral azithromycin in serum, urine, polymorphonuclear leucocytes and inflammatory vs non-inflammatory skin blisters in healthy volunteers","volume":"15","author":"Ballow","year":"1998","journal-title":"Clin Drug Investig"},{"key":"2019042309331412200_dky548-B40","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jac\/dki241","article-title":"Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models","volume":"56","author":"Girard","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"2019042309331412200_dky548-B41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cid\/ciu220","article-title":"Azithromycin versus doxycycline for the treatment of genital chlamydia infection\u2014a meta-analysis of randomized controlled trials","volume":"59","author":"Kong","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2019042309331412200_dky548-B42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s40262-015-0321-z","article-title":"A qualitative review on the pharmacokinetics of antibiotics in saliva: implications on clinical pharmacokinetic monitoring in humans","volume":"55","author":"Kiang","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"2019042309331412200_dky548-B43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/jac\/dkx392","article-title":"Chlamydia trachomatis antimicrobial susceptibility in colorectal and endocervical cells","volume":"73","author":"Foschi","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2019042309331412200_dky548-B44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00007435-199403000-00010","article-title":"Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromycin Gonorrhea Study Group","volume":"21","author":"Handsfield","year":"1994","journal-title":"Sex Transm Dis"},{"key":"2019042309331412200_dky548-B45","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/cid\/ciu521","article-title":"The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea","volume":"59","author":"Kirkcaldy","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2019042309331412200_dky548-B46","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0140-6736(05)67529-0","article-title":"Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study","volume":"366","author":"West","year":"2005","journal-title":"Lancet"},{"key":"2019042309331412200_dky548-B47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1167\/iovs.04-0327","article-title":"Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community","volume":"46","author":"West","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2019042309331412200_dky548-B48","doi-asserted-by":"crossref","first-page":"e37778.","DOI":"10.1371\/journal.pone.0037778","article-title":"Chlamydia trachomatis incidence and re-infection among young women\u2014behavioural and microbiological characteristics","volume":"7","author":"Walker","year":"2012","journal-title":"PLoS One"},{"key":"2019042309331412200_dky548-B49","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1017\/S0950268816000996","article-title":"Higher organism load associated with failure of azithromycin to treat rectal chlamydia","volume":"144","author":"Kong","year":"2016","journal-title":"Epidemiol Infect"},{"key":"2019042309331412200_dky548-B50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/sextrans-2014-051633","article-title":"Spontaneous pharyngeal Chlamydia trachomatis RNA clearance. A cross-sectional study followed by a cohort study of untreated STI clinic patients in Amsterdam, The Netherlands","volume":"91","author":"van Rooijen","year":"2015","journal-title":"Sex Transm Infect"},{"key":"2019042309331412200_dky548-B51","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1001\/jama.1990.03450110064028","article-title":"Ciprofloxacin compared with doxycycline for nongonococcal urethritis: ineffectiveness against Chlamydia trachomatis due to relapsing infection","volume":"264","author":"Hooton","year":"1990","journal-title":"J Am Med Assoc"},{"key":"2019042309331412200_dky548-B52","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/cid\/cis1210","article-title":"Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women","volume":"56","author":"Walker","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2019042309331412200_dky548-B53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12879-015-0781-7","article-title":"Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin","volume":"15","author":"Guschin","year":"2015","journal-title":"BMC Infect Dis"},{"key":"2019042309331412200_dky548-B54","doi-asserted-by":"crossref","first-page":"328.","DOI":"10.3201\/eid2402.170902","article-title":"Use of pristinamycin for macrolide-resistant Mycoplasma genitalium infection","volume":"24","author":"Read","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2019042309331412200_dky548-B55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/sextrans-2016-053060","article-title":"Which azithromycin regimen should be used for treating Mycoplasma genitalium? A meta-analysis","volume":"94","author":"Horner","year":"2018","journal-title":"Sex Transm Infect"},{"key":"2019042309331412200_dky548-B56","article-title":"Outcomes of resistance-guided sequential treatment of Mycoplasma genitalium infections: a prospective evaluation","author":"Read","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2019042309331412200_dky548-B57","doi-asserted-by":"crossref","first-page":"95.","DOI":"10.1186\/1471-2334-14-95","article-title":"Prevalence and types of rectal douches used for anal intercourse: results from an international survey","volume":"14","author":"Javanbakht","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2019042309331412200_dky548-B58","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1089\/aid.2010.0252","article-title":"Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro","volume":"27","author":"Begay","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2019042309331412200_dky548-B59","doi-asserted-by":"crossref","first-page":"e48328.","DOI":"10.1371\/journal.pone.0048328","article-title":"Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity","volume":"7","author":"Dezzutti","year":"2012","journal-title":"PLoS One"},{"key":"2019042309331412200_dky548-B60","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/jac\/dks173","article-title":"Reformulated tenofovir gel for use as a dual compartment microbicide","volume":"67","author":"Dezzutti","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2019042309331412200_dky548-B61","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/OLQ.0b013e31815abb08","article-title":"Lymphogranuloma venereum proctitis in men who have sex with men is associated with anal enema use and high-risk behavior","volume":"35","author":"de Vries","year":"2008","journal-title":"Sex Transm Dis"},{"key":"2019042309331412200_dky548-B62","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/infdis\/146.1.7","article-title":"Hepatitis B in homosexual men: prevalence of infection and factors related to transmission","volume":"146","author":"Schreeder","year":"1982","journal-title":"J Infect Dis"},{"key":"2019042309331412200_dky548-B63","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jac\/dkm476","article-title":"Tissue concentrations: do we ever learn?","volume":"61","author":"Mouton","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2019042309331412200_dky548-B64","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1172\/JCI107348","article-title":"Interaction of intraleukocytic bacteria and antibiotics","volume":"52","author":"Mandell","year":"1973","journal-title":"J Clin Invest"},{"key":"2019042309331412200_dky548-B65","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1128\/IAI.65.6.2420-2427.1997","article-title":"Ultrastructural analysis of primary human urethral epithelial cell cultures infected with Neisseria gonorrhoeae","volume":"65","author":"Harvey","year":"1997","journal-title":"Infect Immun"},{"key":"2019042309331412200_dky548-B66","first-page":"133","article-title":"A subpopulation of intracellular Neisseria gonorrhoeae escapes autophagy-mediated killing inside epithelial cells","volume":"219","author":"Lu","year":"2019","journal-title":"J Infect Dis"},{"key":"2019042309331412200_dky548-B67","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/mpat.2000.0395","article-title":"Intracellular DNA replication and long-term survival of pathogenic mycoplasmas","volume":"29","author":"Dallo","year":"2000","journal-title":"Microb Pathog"},{"key":"2019042309331412200_dky548-B68","doi-asserted-by":"crossref","first-page":"e0177615.","DOI":"10.1371\/journal.pone.0177615","article-title":"Measurement of tissue azithromycin levels in self-collected vaginal swabs post treatment using liquid chromatography and tandem mass spectrometry (LC-MS\/MS)","volume":"12","author":"Vodstrcil","year":"2017","journal-title":"PLoS One"},{"key":"2019042309331412200_dky548-B69","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jac\/dkx427","article-title":"MIC-based dose adjustment: facts and fables","volume":"73","author":"Mouton","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2019042309331412200_dky548-B70","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1093\/jac\/dkq289","article-title":"Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?","volume":"65","author":"Chisholm","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"2019042309331412200_dky548-B71","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1128\/AAC.01433-10","article-title":"Protein binding: do we ever learn?","volume":"55","author":"Zeitlinger","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309331412200_dky548-B72","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1021\/mp300250r","article-title":"Saliva versus plasma pharmacokinetics: theory and application of a salivary excretion classification system","volume":"9","author":"Idkaidek","year":"2012","journal-title":"Mol Pharm"},{"key":"2019042309331412200_dky548-B73","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00044011-199816020-00009","article-title":"A Phase I determination of azithromycin in plasma during a 6-week period in normal volunteers after a standard dose of 500mg once daily for 3 days","volume":"16","author":"Crokaert","year":"1998","journal-title":"Clin Drug Investig"},{"key":"2019042309331412200_dky548-B74","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1128\/AAC.50.3.841-851.2006","article-title":"Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages","volume":"50","author":"Barcia-Macay","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309331412200_dky548-B75","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s15010-001-1072-3","article-title":"Influence of macrolide antibiotics on promotion of resistance in the oral flora of children","volume":"29","author":"Kastner","year":"2001","journal-title":"Infection"},{"key":"2019042309331412200_dky548-B76","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1128\/AAC.02011-12","article-title":"Blood, tissue, and intracellular concentrations of azithromycin during and after end of therapy","volume":"57","author":"Matzneller","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309331412200_dky548-B77","doi-asserted-by":"crossref","first-page":"3151.","DOI":"10.1128\/AAC.02411-14","article-title":"In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains","volume":"58","author":"Jensen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309331412200_dky548-B78","year":"2017"},{"key":"2019042309331412200_dky548-B79","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S1473-3099(18)30162-2","article-title":"Dual antimicrobial therapy for gonorrhoea: what is the role of azithromycin?","volume":"18","author":"Unemo","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2019042309331412200_dky548-B80","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1473-3099(18)30122-1","article-title":"Sustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: an observational study","volume":"18","author":"Fifer","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2019042309331412200_dky548-B81","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s12879-017-2707-z","article-title":"Overall low extended-spectrum cephalosporin resistance but high azithromycin resistance in Neisseria gonorrhoeae in 24 European countries, 2015","volume":"17","author":"Cole","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2019042309331412200_dky548-B82","doi-asserted-by":"crossref","first-page":"S396","DOI":"10.1093\/infdis\/jix145","article-title":"Mycoplasma genitalium infection in men","volume":"216 Suppl 2","author":"Horner","year":"2017","journal-title":"J Infect Dis"},{"key":"2019042309331412200_dky548-B83","first-page":"1","article-title":"Sexually transmitted infections and chlamydia screening in England, 2015","volume":"10","year":"2016","journal-title":"Health Protect Rep"},{"key":"2019042309331412200_dky548-B84","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/sextrans-2017-053461","article-title":"Is previous azithromycin treatment associated with azithromycin resistance in Neisseria gonorrhoeae? A cross-sectional study using national surveillance data in England","volume":"94","author":"Clifton","year":"2018","journal-title":"Sex Transm Infect"},{"key":"2019042309331412200_dky548-B85","first-page":"609","volume-title":"BMC Infect Dis","author":"Day","year":"2018"},{"key":"2019042309331412200_dky548-B86","year":"2016"},{"key":"2019042309331412200_dky548-B87","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1128\/AAC.21.6.957","article-title":"Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents","volume":"21","author":"Patel","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309331412200_dky548-B88","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000238415","article-title":"Human pharmacokinetics and distribution in various tissues of ceftriaxone","volume":"32","author":"Fraschini","year":"1986","journal-title":"Chemotherapy"},{"key":"2019042309331412200_dky548-B89","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/jac\/38.6.969","article-title":"A comparative analysis of pharmacokinetics of ceftriaxone in serum and pleural fluid in humans: a study of once daily administration by intramuscular and intravenous routes","volume":"38","author":"Goonetilleke","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"2019042309331412200_dky548-B90","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jac\/31.suppl_E.39","article-title":"Selection of dose regimens of azithromycin","volume":"31","author":"Foulds","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"2019042309331412200_dky548-B91","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/sextrans-2011-050385","article-title":"Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy","volume":"88","author":"Horner","year":"2012","journal-title":"Sex Transm Infect"},{"key":"2019042309331412200_dky548-B92","doi-asserted-by":"crossref","first-page":"422.","DOI":"10.1136\/sti.2010.044586","article-title":"Azithromycin in the treatment of infection with Neisseria gonorrhoeae","volume":"86","author":"Bignell","year":"2010","journal-title":"Sex Transm Infect"},{"key":"2019042309331412200_dky548-B93","year":"2008"},{"key":"2019042309331412200_dky548-B94","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/AAC.43.1.163","article-title":"Pharmacokinetics in serum and leukocyte exposures of oral azithromycin, 1,500 milligrams, given over a 3- or 5-day period in healthy subjects","volume":"43","author":"Amsden","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309331412200_dky548-B95","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/jac\/dkn032","article-title":"Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin","volume":"61","author":"Lucchi","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2019042309331412200_dky548-B96","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1128\/AAC.00852-06","article-title":"Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen","volume":"51","author":"Liu","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309331412200_dky548-B97","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ijantimicag.2008.01.027","article-title":"Pharmacokinetics of azithromycin in serum and sinus fluid after administration of extended-release and immediate-release formulations in patients with acute bacterial sinusitis","volume":"31","author":"Ehnhage","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"2019042309331412200_dky548-B98","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N Engl J Med"},{"key":"2019042309331412200_dky548-B99","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1056\/NEJM197301252880404","article-title":"Clinical spectrum of pharyngeal gonococcal infection","volume":"288","author":"Wiesner","year":"1973","journal-title":"N Engl J Med"},{"key":"2019042309331412200_dky548-B100","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1128\/JCM.01186-16","article-title":"Neisseria gonorrhoeae bacterial DNA load in the pharynges and saliva of men who have sex with men","volume":"54","author":"Chow","year":"2016","journal-title":"J Clin Microbiol"},{"key":"2019042309331412200_dky548-B101","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1699-0463.1990.tb01054.x","article-title":"Antichlamydial activity of saliva","volume":"98","author":"Gen\u00e7","year":"1990","journal-title":"APMIS"},{"key":"2019042309331412200_dky548-B102","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/sextrans-2014-051731","article-title":"Will targeting oropharyngeal gonorrhoea delay the further emergence of drug-resistant Neisseria gonorrhoeae strains?","volume":"91","author":"Lewis","year":"2015","journal-title":"Sex Transm Infect"},{"key":"2019042309331412200_dky548-B103","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/sextrans-2014-051730","article-title":"Will use of combination cephalosporin\/azithromycin therapy forestall resistance to cephalosporins in Neisseria gonorrhoeae?","volume":"91","author":"Rice","year":"2015","journal-title":"Sex Transm Infect"},{"key":"2019042309331412200_dky548-B104","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/sextrans-2015-052399","article-title":"Detection of Neisseria gonorrhoeae in the pharynx and saliva: implications for gonorrhoea transmission","volume":"92","author":"Chow","year":"2015","journal-title":"Sex Transm Infect"},{"key":"2019042309331412200_dky548-B105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jac\/dkf510","article-title":"Pharmacodynamic and kinetic basis for the selection of pneumococcal resistance in the upper respiratory tract","volume":"50","author":"Soriano","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"2019042309331412200_dky548-B106","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00007691-198206000-00001","article-title":"Doxycycline","volume":"4","author":"Cunha","year":"1982","journal-title":"Ther Drug Monit"},{"key":"2019042309331412200_dky548-B107","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/25.suppl_A.73","article-title":"The pharmacokinetics of azithromycin in human serum and tissues","volume":"25","author":"Foulds","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"2019042309331412200_dky548-B108","first-page":"A42\u20133","article-title":"LB1.5 The efficacy and safety of gentamicin for the treatment of genital, pharyngeal and rectal gonorrhoea: a randomised controlled trial","volume":"93","author":"Ross","year":"2017","journal-title":"Sex Transm Infect"},{"key":"2019042309331412200_dky548-B109","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1128\/IAI.56.6.1625-1632.1988","article-title":"Model for invasion of human tissue culture cells by Neisseria gonorrhoeae","volume":"56","author":"Shaw","year":"1988","journal-title":"Infect Immun"},{"key":"2019042309331412200_dky548-B110","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0003-9969(03)00014-1","article-title":"Estimates, from salivary analyses, of the turnover time of the oral mucosal epithelium in humans and the number of bacteria in an edentulous mouth","volume":"48","author":"Dawes","year":"2003","journal-title":"Arch Oral Biol"},{"key":"2019042309331412200_dky548-B111","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbagen.2014.05.003","article-title":"Mucins: a biologically relevant glycan barrier in mucosal protection","volume":"1850","author":"Corfield","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"2019042309331412200_dky548-B112","year":"2016"},{"key":"2019042309331412200_dky548-B113","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41564-018-0182-y","article-title":"Chlamydia trachomatis paralyses neutrophils to evade the host innate immune response","volume":"3","author":"Rajeeve","year":"2018","journal-title":"Nat Microbiol"},{"key":"2019042309331412200_dky548-B114","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2340\/00015555-2108","article-title":"Five-day azithromycin treatment regimen for Mycoplasma genitalium infection also effectively eradicates Chlamydia trachomatis","volume":"95","author":"Unemo","year":"2015","journal-title":"Acta Derm Venerol"},{"key":"2019042309331412200_dky548-B115","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1128\/AAC.42.11.2914","article-title":"In vitro selection of resistance to four \u03b2-lactams and azithromycin in Streptococcus pneumoniae","volume":"42","author":"Pankuch","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309331412200_dky548-B116","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4103\/0972-124X.118317","article-title":"Salivary pH: a diagnostic biomarker","volume":"17","author":"Baliga","year":"2013","journal-title":"J Indian Soc Periodontol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/5\/1157\/28501076\/dky548.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T16:12:23Z","timestamp":1605543143000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/5\/1157\/5288574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,11]]},"references-count":116,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,1,11]]},"published-print":{"date-parts":[[2019,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky548","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,5]]},"published":{"date-parts":[[2019,1,11]]}}}